A myomesin mutation associated with hypertrophic cardiomyopathy deteriorates dimerisation properties.
about
Genetic association of left ventricular mass assessed by M-mode and two-dimensional echocardiography.Dissection of Z-disc myopalladin gene network involved in the development of restrictive cardiomyopathy using system genetics approachThe effect of disease on human cardiac protein expression profiles in paired samples from right and left ventricles.Cardiac titin and heart disease.RNAseq analysis of heart tissue from mice treated with atenolol and isoproterenol reveals a reciprocal transcriptional response.Titin is a major human disease gene.Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathyG9a inhibits MEF2C activity to control sarcomere assembly.Copy number variation analysis in 98 individuals with PHACE syndrome.Mechanisms of disease: hypertrophic cardiomyopathy.The sarcomeric M-region: a molecular command center for diverse cellular processes.Functional analysis of slow myosin heavy chain 1 and myomesin-3 in sarcomere organization in zebrafish embryonic slow muscles.Overview of the Muscle Cytoskeleton.A One Health Approach to Hypertrophic Cardiomyopathy.Molecular basis of the mechanical hierarchy in myomesin dimers for sarcomere integrity.
P2860
Q30357928-70756264-C064-454B-90E1-31ED61822928Q33623284-F3A9E377-DC58-45D4-921E-16D2545BB08CQ34152309-D50CB71A-1032-4EE4-9780-8A635A39AB44Q34721100-1C39AAF1-8EAE-455D-80BC-CEC6FCDDB15CQ36125623-4E3A0573-E914-4EDD-A8C7-74B82DAA6559Q36675841-0102FE93-8644-4856-B6AB-8259CAF341C5Q37269947-E0C38B77-E6FC-411E-B4EE-CE97907A7B70Q37282370-E6605B57-F914-4295-AB73-0D6FA99B281CQ37677825-68047807-82D2-41E5-BA1A-FB0224A74B53Q37949516-C0849A78-A3BF-44AD-A0DA-CE483C684DB7Q38471353-5650B341-43B2-4537-B8F4-EF630E43AFB0Q38578182-4993FBE6-9B05-43FC-898E-8D5CE0FAF61AQ39391006-C562567E-5FEC-4380-8074-28BB1A2D6193Q41687674-2168804B-ED0F-4ADB-AD00-D919A95CDCBEQ42249535-2919DF78-D148-4077-8A5A-A8BC2FEE521F
P2860
A myomesin mutation associated with hypertrophic cardiomyopathy deteriorates dimerisation properties.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
A myomesin mutation associated ...... rates dimerisation properties.
@en
A myomesin mutation associated ...... rates dimerisation properties.
@nl
type
label
A myomesin mutation associated ...... rates dimerisation properties.
@en
A myomesin mutation associated ...... rates dimerisation properties.
@nl
prefLabel
A myomesin mutation associated ...... rates dimerisation properties.
@en
A myomesin mutation associated ...... rates dimerisation properties.
@nl
P2093
P1476
A myomesin mutation associated ...... orates dimerisation properties
@en
P2093
Aleksandra Michalewska-Włudarczyk
Anna Wycisk
Cemil Ozcelik
Ingo Morano
Joachim Behlke
Michal Tendera
Romy Siegert
P304
P356
10.1016/J.BBRC.2011.01.056
P407
P577
2011-01-20T00:00:00Z